{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:54:44Z","timestamp":1783461284519,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gallic acid (GA) has been reported to have beneficial effects on cancer, vascular calcification, and diabetes-induced myocardial dysfunction. We hypothesized that GA controls hypertension via oxidative stress response regulation in an animal model for essential hypertension. Spontaneously hypertensive rats (SHRs) were administered GA for 16 weeks. GA treatment lowered elevated systolic blood pressure in SHRs through the inhibition of vascular contractility and components of the renin-angiotensin II system. In addition, GA administration reduced aortic wall thickness and body weight in SHRs. In SHRs, GA attenuated left ventricular hypertrophy and reduced the expression of cardiac-specific transcription factors. NADPH oxidase 2 (Nox2) and GATA4 mRNA expression was induced in SHR hearts and angiotensin II-treated H9c2 cells; this expression was downregulated by GA treatment. Nox2 promoter activity was increased by the synergistic action of GATA4 and Nkx2-5. GA seems to regulate oxidative stress by inhibiting the DNA binding activity of GATA4 in the rat Nox2 promoter. GA reduced the GATA4-induced Nox activity in SHRs and angiotensin II-treated H9c2 cells. GA administration reduced the elevation of malondialdehyde levels in heart tissue obtained from SHRs. These findings suggest that GA is a potential therapeutic agent for treating cardiac hypertrophy and oxidative stress in SHRs.<\/jats:p>","DOI":"10.1038\/s41598-017-15925-1","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T10:47:38Z","timestamp":1510224458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats"],"prefix":"10.1038","volume":"7","author":[{"given":"Li","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe Hao","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwi Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Mi","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Quan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhee","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Jin","family":"Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"15925_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0733-8651(02)00004-8","volume":"20","author":"GA Mensah","year":"2002","unstructured":"Mensah, G. A., Croft, J. B. & Giles, W. H. The heart, kidney, and brain as target organs in hypertension. Cardiol Clin \n                           20, 225\u2013247 (2002).","journal-title":"Cardiol Clin"},{"issue":"Suppl 2","key":"15925_CR2","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1038\/sj.jhh.1001797","volume":"18","author":"P Verdecchia","year":"2004","unstructured":"Verdecchia, P. et al. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? J Hum Hypertens \n                           18(Suppl 2), S23\u201328 (2004).","journal-title":"J Hum Hypertens"},{"key":"15925_CR3","first-page":"577","volume":"16","author":"TH Marwick","year":"2015","unstructured":"Marwick, T. H. et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger. Eur Heart J Cardiovasc Imaging \n                           16, 577\u2013605 (2015).","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"15925_CR4","first-page":"221","volume":"97","author":"J Julien","year":"2004","unstructured":"Julien, J., Tranche, C. & Souchet, T. [Left ventricular hypertrophy in hypertensive patients. Epidemiology and prognosis]. Arch Mal Coeur Vaiss \n                           97, 221\u2013227 (2004).","journal-title":"Epidemiology and prognosis]. Arch Mal Coeur Vaiss"},{"issue":"Suppl 5","key":"15925_CR5","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1097\/00005344-198608005-00013","volume":"8","author":"G Bianchi","year":"1986","unstructured":"Bianchi, G. et al. Genetic and experimental hypertension in the animal model-similarities and dissimilarities to the development of human hypertension. J Cardiovasc Pharmacol \n                           8(Suppl 5), S64\u201370 (1986).","journal-title":"J Cardiovasc Pharmacol"},{"key":"15925_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","volume":"39","author":"SA Doggrell","year":"1998","unstructured":"Doggrell, S. A. & Brown, L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res \n                           39, 89\u2013105 (1998).","journal-title":"Cardiovasc Res"},{"key":"15925_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","volume":"139","author":"S Oparil","year":"2003","unstructured":"Oparil, S., Zaman, M. A. & Calhoun, D. A. Pathogenesis of hypertension. Ann Intern Med \n                           139, 761\u2013776 (2003).","journal-title":"Ann Intern Med"},{"key":"15925_CR8","first-page":"299","volume":"3","author":"AR Dyer","year":"1989","unstructured":"Dyer, A. R. & Elliott, P. The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens \n                           3, 299\u2013308 (1989).","journal-title":"J Hum Hypertens"},{"key":"15925_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11906-015-0539-z","volume":"17","author":"AJ Woodiwiss","year":"2015","unstructured":"Woodiwiss, A. J. & Norton, G. R. Obesity and left ventricular hypertrophy: the hypertension connection. Curr Hypertens Rep \n                           17, 539 (2015).","journal-title":"Curr Hypertens Rep"},{"key":"15925_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/11593700-000000000-00000","volume":"19","author":"G Salvetti","year":"2012","unstructured":"Salvetti, G. et al. Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev \n                           19, 33\u201339 (2012).","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"15925_CR11","doi-asserted-by":"publisher","first-page":"5K","DOI":"10.1016\/S0002-9149(99)00399-9","volume":"84","author":"PW de Leeuw","year":"1999","unstructured":"de Leeuw, P. W. How do angiotensin II receptor antagonists affect blood pressure? Am J Cardiol \n                           84, 5K\u20136K (1999).","journal-title":"Am J Cardiol"},{"key":"15925_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/01.CIR.0000030181.63741.56","volume":"106","author":"S Kagiyama","year":"2002","unstructured":"Kagiyama, S. et al. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation \n                           106, 909\u2013912 (2002).","journal-title":"Circulation"},{"key":"15925_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","volume":"49","author":"E Takimoto","year":"2007","unstructured":"Takimoto, E. & Kass, D. A. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension \n                           49, 241\u2013248 (2007).","journal-title":"Hypertension"},{"key":"15925_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/cmi.2014.89","volume":"12","author":"A Panday","year":"2015","unstructured":"Panday, A., Sahoo, M. K., Osorio, D. & Batra, S. NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol \n                           12, 5\u201323 (2015).","journal-title":"Cell Mol Immunol"},{"key":"15925_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3858\/emm.2009.41.4.058","volume":"41","author":"J El-Benna","year":"2009","unstructured":"El-Benna, J., Dang, P. M., Gougerot-Pocidalo, M. A., Marie, J. C. & Braut-Boucher, F. p47phox, the phagocyte NADPH oxidase\/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med \n                           41, 217\u2013225 (2009).","journal-title":"Exp Mol Med"},{"key":"15925_CR16","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1098\/rstb.2005.1772","volume":"360","author":"A Cave","year":"2005","unstructured":"Cave, A., Grieve, D., Johar, S., Zhang, M. & Shah, A. M. NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology. Philos Trans R Soc Lond B Biol Sci \n                           360, 2327\u20132334 (2005).","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"15925_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1573402111666150529130922","volume":"11","author":"N Sinha","year":"2015","unstructured":"Sinha, N. & Dabla, P. K. Oxidative stress and antioxidants in hypertension-a current review. Curr Hypertens Rev \n                           11, 132\u2013142 (2015).","journal-title":"Curr Hypertens Rev"},{"key":"15925_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","volume":"25","author":"GR Drummond","year":"2014","unstructured":"Drummond, G. R. & Sobey, C. G. Endothelial NADPH oxidases: which NOX to target in vascular disease? Trends Endocrinol Metab \n                           25, 452\u2013463 (2014).","journal-title":"Trends Endocrinol Metab"},{"key":"15925_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cjca.2015.02.008","volume":"31","author":"AC Montezano","year":"2015","unstructured":"Montezano, A. C. et al. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol \n                           31, 631\u2013641 (2015).","journal-title":"Can J Cardiol"},{"key":"15925_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11010-008-9803-8","volume":"317","author":"W Zhao","year":"2008","unstructured":"Zhao, W., Zhao, T., Chen, Y., Ahokas, R. A. & Sun, Y. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem \n                           317, 43\u201350 (2008).","journal-title":"Mol Cell Biochem"},{"key":"15925_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/hrt.2005.068270","volume":"93","author":"M Seddon","year":"2007","unstructured":"Seddon, M., Looi, Y. H. & Shah, A. M. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart \n                           93, 903\u2013907 (2007).","journal-title":"Heart"},{"key":"15925_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/0974-8490.89743","volume":"3","author":"SS Patel","year":"2011","unstructured":"Patel, S. S. & Goyal, R. K. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy Res \n                           3, 239\u2013245 (2011).","journal-title":"Pharmacognosy Res"},{"key":"15925_CR23","doi-asserted-by":"publisher","first-page":"M1299","DOI":"10.1111\/1750-3841.12902","volume":"80","author":"D Shao","year":"2015","unstructured":"Shao, D. et al. Inhibition of Gallic Acid on the Growth and Biofilm Formation of Escherichia coli and Streptococcus mutans. J Food Sci \n                           80, M1299\u20131305 (2015).","journal-title":"J Food Sci"},{"key":"15925_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/jbt.21575","volume":"28","author":"K Wang","year":"2014","unstructured":"Wang, K., Zhu, X., Zhang, K., Zhu, L. & Zhou, F. Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells. J Biochem Mol Toxicol \n                           28, 387\u2013393 (2014).","journal-title":"J Biochem Mol Toxicol"},{"key":"15925_CR25","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/ptr.3452","volume":"25","author":"HJ Jung","year":"2011","unstructured":"Jung, H. J. & Lim, C. J. The antiangiogenic and antinociceptive activities of n-propyl gallate. Phytother Res \n                           25, 1570\u20131573 (2011).","journal-title":"Phytother Res"},{"key":"15925_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4155\/ppa.15.14","volume":"4","author":"S Choubey","year":"2015","unstructured":"Choubey, S., Varughese, L. R., Kumar, V. & Beniwal, V. Medicinal importance of gallic acid and its ester derivatives: a patent review. Pharm Pat Anal \n                           4, 305\u2013315 (2015).","journal-title":"Pharm Pat Anal"},{"key":"15925_CR27","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.foodchem.2012.11.022","volume":"138","author":"MT Mansouri","year":"2013","unstructured":"Mansouri, M. T. et al. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem \n                           138, 1028\u20131033 (2013).","journal-title":"Food Chem"},{"key":"15925_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2009.05.003","volume":"615","author":"P Stanely Mainzen Prince","year":"2009","unstructured":"Stanely Mainzen Prince, P., Priscilla, H. & Devika, P. T. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. Eur J Pharmacol \n                           615, 139\u2013143 (2009).","journal-title":"Eur J Pharmacol"},{"key":"15925_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.vph.2014.08.005","volume":"63","author":"HJ Kee","year":"2014","unstructured":"Kee, H. J. et al. Gallic acid inhibits vascular calcification through the blockade of BMP2-Smad1\/5\/8 signaling pathway. Vascul Pharmacol \n                           63, 71\u201378 (2014).","journal-title":"Vascul Pharmacol"},{"key":"15925_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.vph.2015.04.006","volume":"72","author":"SY Choi","year":"2015","unstructured":"Choi, S. Y. et al. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes. Vascul Pharmacol \n                           72, 130\u2013140 (2015).","journal-title":"Vascul Pharmacol"},{"key":"15925_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep34790","volume":"6","author":"Y Ryu","year":"2016","unstructured":"Ryu, Y. et al. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Sci Rep \n                           6, 34790 (2016).","journal-title":"Sci Rep"},{"key":"15925_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00210-012-0770-y","volume":"385","author":"YM Seok","year":"2012","unstructured":"Seok, Y. M., Jang, E. J., Reiser, O., Hager, M. & Kim, I. K. 17beta-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner. Naunyn Schmiedebergs Arch Pharmacol \n                           385, 945\u2013948 (2012).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"15925_CR33","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.110.160853","volume":"56","author":"YM Seok","year":"2010","unstructured":"Seok, Y. M. et al. Enhanced Ca2+ -dependent activation of phosphoinositide 3-kinase class IIalpha isoform-Rho axis in blood vessels of spontaneously hypertensive rats. Hypertension \n                           56, 934\u2013941 (2010).","journal-title":"Hypertension"},{"key":"15925_CR34","doi-asserted-by":"publisher","first-page":"7700","DOI":"10.1074\/jbc.M611198200","volume":"282","author":"HJ Kee","year":"2007","unstructured":"Kee, H. J. et al. Enhancer ofpolycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation. J Biol Chem \n                           282, 7700\u20137709 (2007).","journal-title":"J Biol Chem"},{"key":"15925_CR35","first-page":"8","volume":"17","author":"JE Hall","year":"1991","unstructured":"Hall, J. E. The renin-angiotensin system: renal actions and blood pressure regulation. Compr Ther \n                           17, 8\u201317 (1991).","journal-title":"Compr Ther"},{"key":"15925_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/01.RES.35.5.775","volume":"35","author":"S Sen","year":"1974","unstructured":"Sen, S., Tarazi, R. C., Khairallah, P. A. & Bumpus, F. M. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res \n                           35, 775\u2013781 (1974).","journal-title":"Circ Res"},{"key":"15925_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/157340311799960618","volume":"7","author":"S Kohli","year":"2011","unstructured":"Kohli, S., Ahuja, S. & Rani, V. Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy. Curr Cardiol Rev \n                           7, 262\u2013271 (2011).","journal-title":"Curr Cardiol Rev"},{"key":"15925_CR38","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.3892\/mmr.2014.2492","volume":"10","author":"X Fan","year":"2014","unstructured":"Fan, X. et al. Novel mechanism of intrarenal angiotensin II-induced sodium\/proton exchanger 3 expression by losartan in spontaneously hypertensive rats. Mol Med Rep \n                           10, 2483\u20132488 (2014).","journal-title":"Mol Med Rep"},{"key":"15925_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/aap.12001","volume":"32","author":"P Castro-Moreno","year":"2012","unstructured":"Castro-Moreno, P. et al. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR. Auton Autacoid Pharmacol \n                           32, 61\u201369 (2012).","journal-title":"Auton Autacoid Pharmacol"},{"key":"15925_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.109.142422","volume":"56","author":"SR Datla","year":"2010","unstructured":"Datla, S. R. & Griendling, K. K. Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension \n                           56, 325\u2013330 (2010).","journal-title":"Hypertension"},{"key":"15925_CR41","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.etap.2015.02.006","volume":"39","author":"N Kang","year":"2015","unstructured":"Kang, N. et al. Gallic acid isolated from Spirogyra sp. improves cardiovascular disease through a vasorelaxant and antihypertensive effect. Environ Toxicol Pharmacol \n                           39, 764\u2013772 (2015).","journal-title":"Environ Toxicol Pharmacol"},{"key":"15925_CR42","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1111\/bph.13172","volume":"172","author":"J Schuchard","year":"2015","unstructured":"Schuchard, J. et al. Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)\/Mas-dependent pathway. Br J Pharmacol \n                           172, 3764\u20133778 (2015).","journal-title":"Br J Pharmacol"},{"key":"15925_CR43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","volume":"92","author":"H Akazawa","year":"2003","unstructured":"Akazawa, H. & Komuro, I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res \n                           92, 1079\u20131088 (2003).","journal-title":"Circ Res"},{"key":"15925_CR44","doi-asserted-by":"publisher","first-page":"30245","DOI":"10.1074\/jbc.M102174200","volume":"276","author":"Q Liang","year":"2001","unstructured":"Liang, Q. et al. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem \n                           276, 30245\u201330253 (2001).","journal-title":"J Biol Chem"},{"key":"15925_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.109.149187","volume":"56","author":"S Wind","year":"2010","unstructured":"Wind, S. et al. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1\/2 is reversed by NADPH oxidase inhibition. Hypertension \n                           56, 490\u2013497 (2010).","journal-title":"Hypertension"},{"key":"15925_CR46","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1039\/C5FO01101A","volume":"7","author":"M Romero","year":"2016","unstructured":"Romero, M. et al. Antihypertensive effects of oleuropein-enriched olive leaf extract in spontaneously hypertensive rats. Food Funct \n                           7, 584\u2013593 (2016).","journal-title":"Food Funct"},{"key":"15925_CR47","doi-asserted-by":"publisher","first-page":"35373","DOI":"10.1074\/jbc.M702175200","volume":"282","author":"MR Abid","year":"2007","unstructured":"Abid, M. R., Spokes, K. C., Shih, S. C. & Aird, W. C. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem \n                           282, 35373\u201335385 (2007).","journal-title":"J Biol Chem"},{"key":"15925_CR48","doi-asserted-by":"publisher","first-page":"726940","DOI":"10.1155\/2012\/726940","volume":"2012","author":"JL Miguel-Carrasco","year":"2012","unstructured":"Miguel-Carrasco, J. L. et al. Blockade of TGF-beta 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats. Oxid Med Cell Longev \n                           2012, 726940 (2012).","journal-title":"Oxid Med Cell Longev"},{"key":"15925_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jash.2011.02.001","volume":"5","author":"AM Briones","year":"2011","unstructured":"Briones, A. M. et al. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J Am Soc Hypertens \n                           5, 137\u2013153 (2011).","journal-title":"J Am Soc Hypertens"},{"key":"15925_CR50","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.jacc.2006.01.071","volume":"47","author":"H Li","year":"2006","unstructured":"Li, H. et al. Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol \n                           47, 2536\u20132544 (2006).","journal-title":"J Am Coll Cardiol"},{"key":"15925_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/hy0202.103264","volume":"39","author":"T Chabrashvili","year":"2002","unstructured":"Chabrashvili, T. et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension \n                           39, 269\u2013274 (2002).","journal-title":"Hypertension"},{"key":"15925_CR52","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/01.STR.0000112974.37028.58","volume":"35","author":"TM Paravicini","year":"2004","unstructured":"Paravicini, T. M., Chrissobolis, S., Drummond, G. R. & Sobey, C. G. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke \n                           35, 584\u2013589 (2004).","journal-title":"Stroke"},{"key":"15925_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yjmcc.2014.02.002","volume":"73","author":"CM Sag","year":"2014","unstructured":"Sag, C. M., Santos, C. X. & Shah, A. M. Redox regulation of cardiac hypertrophy. J Mol Cell Cardiol \n                           73, 103\u2013111 (2014).","journal-title":"J Mol Cell Cardiol"},{"key":"15925_CR54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/01.HYP.0000032031.30374.32","volume":"40","author":"JM Li","year":"2002","unstructured":"Li, J. M., Gall, N. P., Grieve, D. J., Chen, M. & Shah, A. M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension \n                           40, 477\u2013484 (2002).","journal-title":"Hypertension"},{"key":"15925_CR55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/jcp.56.3.194","volume":"56","author":"PA Krijnen","year":"2003","unstructured":"Krijnen, P. A. et al. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol \n                           56, 194\u2013199 (2003).","journal-title":"J Clin Pathol"},{"key":"15925_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2005.08.022","volume":"40","author":"AC Brewer","year":"2006","unstructured":"Brewer, A. C., Sparks, E. C. & Shah, A. M. Transcriptional regulation of the NADPH oxidase isoform, Nox1, in colon epithelial cells: role of GATA-binding factor(s). Free Radic Biol Med \n                           40, 260\u2013274 (2006).","journal-title":"Free Radic Biol Med"},{"key":"15925_CR57","doi-asserted-by":"publisher","first-page":"e5698","DOI":"10.1371\/journal.pone.0005698","volume":"4","author":"AM Riazi","year":"2009","unstructured":"Riazi, A. M. et al. NKX2-5 regulates the expression of beta-catenin and GATA4 in ventricular myocytes. PLoS One \n                           4, e5698 (2009).","journal-title":"PLoS One"},{"key":"15925_CR58","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1128\/MCB.18.6.3120","volume":"18","author":"Y Lee","year":"1998","unstructured":"Lee, Y. et al. The cardiac tissue-restricted homeobox protein Csx\/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol Cell Biol \n                           18, 3120\u20133129 (1998).","journal-title":"Mol Cell Biol"},{"key":"15925_CR59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31254\/jsir.2014.3216","volume":"3","author":"K Ramya","year":"2014","unstructured":"Ramya, K., Mohandas, S. R. & Ashok, K. J. Evaluation of diuretic activity of gallic acid in normal rats. J Sci Innov Res \n                           3, 217\u2013220 (2014).","journal-title":"J Sci Innov Res"},{"key":"15925_CR60","doi-asserted-by":"publisher","first-page":"H688","DOI":"10.1152\/ajpheart.01014.2009","volume":"298","author":"H Li","year":"2010","unstructured":"Li, H. et al. Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am J Physiol Heart Circ Physiol \n                           298, H688\u2013698 (2010).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"15925_CR61","doi-asserted-by":"publisher","first-page":"e001949","DOI":"10.1161\/JAHA.115.001949","volume":"4","author":"AM Prasad","year":"2015","unstructured":"Prasad, A. M. et al. Calcium\/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function. J Am Heart Assoc \n                           4, e001949 (2015).","journal-title":"J Am Heart Assoc"},{"key":"15925_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/A:1010899724222","volume":"220","author":"D Hagemann","year":"2001","unstructured":"Hagemann, D., Bohlender, J., Hoch, B., Krause, E. G. & Karczewski, P. Expression of Ca2+\/calmodulin-dependent protein kinase II delta-subunit isoforms in rats with hypertensive cardiac hypertrophy. Mol Cell Biochem \n                           220, 69\u201376 (2001).","journal-title":"Mol Cell Biochem"},{"key":"15925_CR63","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.toxlet.2016.09.010","volume":"262","author":"QY Yi","year":"2016","unstructured":"Yi, Q. Y. et al. Chronic infusion of epigallocatechin-3-O-gallate into the hypothalamic paraventricular nucleus attenuates hypertension and sympathoexcitation by restoring neurotransmitters and cytokines. Toxicol Lett \n                           262, 105\u2013113 (2016).","journal-title":"Toxicol Lett"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15925-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15925-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15925-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:40:32Z","timestamp":1671802832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15925-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15925"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15925-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]},"assertion":[{"value":"6 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15607"}}